Vitiligo: Generalized well circumscribed patches of leukoderma that are generally distributed over symmetric body locations and is due to autoimmune destruction of melanocytes.
| Name | L12_VITILIGO |
|---|---|
| Long name | Vitiligo |
| Hospital Discharge registry | ICD-10: L80, ICD-9: 7090F, ICD-8: 70905 |
| Cause of Death registry | ICD-10: L80, ICD-9: 7090F, ICD-8: 70905 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
| Latin name | Vitiligo |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 131 | 76 | 55 |
| Unadjusted prevalence (%) | 0.06 | 0.06 | 0.06 |
| Mean age at first event (years) | 42.79 | 42.72 | 42.88 |
| Case fatality at 5-years (%) | 1.53 | 0.00 | 3.64 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 29.01 | 31.58 | 25.45 |
before Vitiligo
after Vitiligo
Loading survival analyses plot…
Loading survival analyses table…